Y-Intercept (HK)’s Novavax NVAX Stock Holding History

Y-Intercept (HK)’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$338K	Buy	+35,842	New	+$321K	0.01%	1429
2022 Q3	–	Sell	-5,115	Closed	-$263K	–	1180
2022 Q2	$263K	Buy	+5,115	New	+$265K	0.03%	626
2021 Q3	–	Sell	-5,617	Closed	-$1.19M	–	832
2021 Q2	$1.19M	Buy	5,617 +3,454	+160%	+$633K	0.3%	65
2021 Q1	$375K	Buy	2,163 +75	+4%	+$14.9K	0.1%	325
2020 Q4	$248K	Buy	+2,088	New	+$222K	0.1%	375

Other funds holding NVAX

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Bulwark Capital Fernandina Beach, Florida $178M AUM 11.44% 1-Year Est. Return

HNB

Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

Y-Intercept (HK)'s NVAX Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Novavax (NVAX) in Q2 2026: 35,842 shares worth $338K. The stake represents 0.01% of the portfolio and ranks #1429 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in NVAX as recently as Q2 2022.

Y-Intercept (HK) first reported a position in NVAX in Q4 2020 and has held it in 5 quarters since. The position peaked at $1.19M in Q2 2021. 20 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Y-Intercept (HK) held 35,842 shares of Novavax worth $338K as of Q2 2026.
Novavax was a new Y-Intercept (HK) position in Q2 2026.
Novavax made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1429 holding.
Y-Intercept (HK) first reported a position in Novavax in Q4 2020 and has held it in 5 quarters since.
Y-Intercept (HK)'s Novavax position peaked at $1.19M in Q2 2021.
20 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.